Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biomerica (BMRA) Receivables (2016 - 2026)

Biomerica's Receivables history spans 16 years, with the latest figure at $1.9 million for Q1 2026.

  • Quarterly results put Receivables at $1.9 million for Q1 2026, down 25.07% from a year ago — trailing twelve months through Feb 2026 was $1.9 million (down 25.07% YoY), and the annual figure for FY2025 was $1.5 million, down 22.22%.
  • Receivables for Q1 2026 was $1.9 million at Biomerica, down from $2.0 million in the prior quarter.
  • In the past five years, Receivables ranged from a high of $3.1 million in Q3 2024 to a low of $772000.0 in Q1 2023.
  • The 5-year median for Receivables is $1.9 million (2026), against an average of $1.9 million.
  • The sharpest move saw Receivables crashed 54.6% in 2022, then skyrocketed 195.73% in 2024.
  • Year by year, Receivables stood at $850014.0 in 2022, then skyrocketed by 153.64% to $2.2 million in 2023, then rose by 24.26% to $2.7 million in 2024, then dropped by 25.72% to $2.0 million in 2025, then dropped by 3.57% to $1.9 million in 2026.
  • According to Business Quant data, Receivables over the past three periods came in at $1.9 million, $2.0 million, and $2.5 million for Q1 2026, Q4 2025, and Q3 2025 respectively.